SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011141
Filing Date
2023-06-15
Accepted
2023-06-15 16:30:28
Documents
19
Period of Report
2023-06-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K edit-20230614x8k.htm   iXBRL 8-K 40526
2 EX-1.1 edit-20230614xex1d1.htm EX-1.1 219357
3 EX-5.1 edit-20230614xex5d1.htm EX-5.1 13833
4 EX-99.1 edit-20230614xex99d1.htm EX-99.1 10221
5 EX-99.2 edit-20230614xex99d2.htm EX-99.2 9551
6 GRAPHIC edit-20230614xex5d1001.jpg GRAPHIC 5920
7 GRAPHIC edit-20230614xex99d1001.jpg GRAPHIC 5856
8 GRAPHIC edit-20230614xex99d2001.jpg GRAPHIC 5883
  Complete submission text file 0001558370-23-011141.txt   489446

Data Files

Seq Description Document Type Size
9 EX-101.SCH edit-20230614.xsd EX-101.SCH 3150
10 EX-101.LAB edit-20230614_lab.xml EX-101.LAB 15240
11 EX-101.PRE edit-20230614_pre.xml EX-101.PRE 9831
13 EXTRACTED XBRL INSTANCE DOCUMENT edit-20230614x8k_htm.xml XML 4672
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37687 | Film No.: 231017808
SIC: 2836 Biological Products, (No Diagnostic Substances)